ustekinumab
- Product NDC
- 57894-441
- 11-digit product format
- 578940441
- Labeler code
- 57894
- Product ID
- 57894-441_d7f96963-2754-4e7b-aebc-66e778c275eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ustekinumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Janssen Biotech, Inc.
- Application
- BLA125261
- Marketing category
- BLA
- Marketing start
- 2025-04-01
- Substance
- USTEKINUMAB
- Active strength
- 90 mg/mL
- Pharmacologic classes
- Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ustekinumab
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| USTEKINUMAB | 90 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | FU77B4U5Z0 |
| Rxcui | 853350, 853355, 1654077, 1811255 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 57894-441-01 | ustekinumab | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 6 |
| 57894-441-01 | ustekinumab | 1 mL in 1 SYRINGE | INJECTION, SOLUTION | 1 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 57894-441 | USTEKINUMAB INJECTION, SOLUTION USTEKINUMAB SOLUTION [JANSSEN BIOTECH, INC.] | 4 | Current NDC, 2 package rows | 20250410_23b486eb-f48d-47d4-815e-1313d4ebfbfa.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 57894-441-01 | 57894044101 | 1 SYRINGE in 1 CARTON (57894-441-01) / 1 mL in 1 SYRINGE | 1 syringe | 2025-04-01 | No | No | Current |